Further Warning on SGLT2 Inhibitor Use and DKA Risk in COVID-19 ...Middle East

Medscape - News
A cluster of cases of diabetic ketoacidosis in which there was no hyperglycemia supports recommendations that SGLT2 inhibitors be discontinued in patients with type 2 diabetes who become ill with COVID-19. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Further Warning on SGLT2 Inhibitor Use and DKA Risk in COVID-19 )

Apple Storegoogle play

Also on site :